Abbott initiates Voyager clinical trial for investigational TAVI system
ABT•Abbott initiated the Voyager clinical trial for its investigational Encantor software-guided TAVI system to treat aortic stenosis and plans to start a U.S. pivotal trial in the coming months.
1. Trial plans
Abbott said it initiated the Voyager clinical trial for the investigational Encantor software-guided balloon-expandable TAVI system. The company plans to initiate a pivotal trial for Encantor TAVI in the U.S. in the coming months.




